Literature DB >> 6109149

Oral mexiletine in high-risk patients after myocardial infarction.

D A Chamberlain, D E Jewitt, D G Julian, R W Campbell, D M Boyle, R G Shanks.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6109149     DOI: 10.1016/s0140-6736(80)92395-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  14 in total

Review 1.  Antiarrhythmic drug classifications. A critical appraisal of their history, present status, and clinical relevance.

Authors:  S Nattel
Journal:  Drugs       Date:  1991-05       Impact factor: 9.546

2.  Electrophysiological testing after acute myocardial infarction.

Authors:  S M Cobbe
Journal:  Br Med J (Clin Res Ed)       Date:  1986-05-17

Review 3.  Mexiletine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias.

Authors:  J P Monk; R N Brogden
Journal:  Drugs       Date:  1990-09       Impact factor: 9.546

4.  A trial of intravenous and oral mexiletine in acute myocardial infarction.

Authors:  H C Smyllie; J W Doar; C D Head; R J Leggett
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

5.  The end of clinical freedom.

Authors:  J R Hampton
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-29

6.  After the infarct.

Authors:  C M Oakley
Journal:  Br Med J (Clin Res Ed)       Date:  1983-09-03

Review 7.  Sudden cardiac death and acute coronary thrombosis.

Authors:  S M Cobbe
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-12

8.  Recasting the approach to the treatment of potentially malignant ventricular arrhythmias after the CAST study.

Authors:  A Bayés de Luna; J Guindo; J Borja; M Roman; C Madoery
Journal:  Cardiovasc Drugs Ther       Date:  1990-06       Impact factor: 3.727

9.  A trial of prophylactic mexiletine in home coronary care.

Authors:  J A Bell; J M Thomas; J R Isaacson; N J Snell; D W Holt
Journal:  Br Heart J       Date:  1982-09

Review 10.  The role of pharmacotherapy in the prevention of sudden cardiac death in patients with heart failure.

Authors:  Phillip A Weeks; Adam Sieg; Jennifer Ann Gass; Indranee Rajapreyar
Journal:  Heart Fail Rev       Date:  2016-07       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.